Adelaide Research & Scholarship: Search

Search

Results 1-10 of 31 (Search time: 0.003 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2001	Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function	Buchanan, G.; Yang, M.; Harris, J.; Nahm, H.; Han, G.; Moore, N.; Bentel, J.; Matusik, R.; Horsfall, D.; Marshall, V.; Greenberg, N.; Tilley, W.
	2006	Suppression of androgen receptor signaling in prostate cancer cells by an inhibitory receptor variant	Butler, L.; Centenera, M.; Neufing, P.; Buchanan, G.; Choong, C.; Ricciardelli, C.; Saint, K.; Lee, M.; Ochnik, A.; Yang, M.; Brown, M.; Tilley, W.
	2001	Collocation of androgen receptor gene mutations in prostate cancer	Buchanan, G.; Greenberg, N.; Scher, H.; Harris, J.; Marshall, V.; Tilley, W.
	2007	Androgen receptor coregulators and their involvement in the development and progression of prostate cancer	Chmelar, R.; Buchanan, G.; Need, E.; Tilley, W.; Greenberg, N.
	2004	Androgen receptor signaling: mechanism of interleukin-6 inhibition	Jia, L.; Choong, C.; Ricciardelli, C.; Kim, J.; Tilley, W.; Coetzee, G.
	2017	Novel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancer	Ponnusamy, S.; Coss, C.; Thiyagarajan, T.; Watts, K.; Hwang, D.-J.; He, Y.; Selth, L.; McEwan, I.; Duke, C.; Pagadala, J.; Singh, G.; Wake, R.; Ledbetter, C.; Tilley, W.; Moldoveanu, T.; Dalton, J.; Miller, D.; Narayanan, R.
	2017	Novel androgen receptor coregulator GRHL2 exerts both oncogenic and antimetastatic functions in prostate cancer	Paltoglou, S.; Das, R.; Townley, S.; Hickey, T.; Tarulli, G.; Coutinho, I.; Fernandes, R.; Hanson, A.; Denis, I.; Carroll, J.; Dehm, S.; Raj, G.; Plymate, S.; Tilley, W.; Selth, L.
	2014	Androgen signalling and steroid receptor crosstalk in endocrine cancers	Claessens, F.; Tilley, W.
	2013	Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression	Butler, M.; Ricciardelli, C.; Tilley, W.; Hickey, T.
	2008	Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potential	Ricciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.